Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

1.34USD
9:00pm BST
Change (% chg)

$-0.04 (-2.90%)
Prev Close
$1.38
Open
$1.37
Day's High
$1.40
Day's Low
$1.32
Volume
7,975
Avg. Vol
58,443
52-wk High
$8.50
52-wk Low
$1.19

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 0.80
Market Cap(Mil.): $19.05
Shares Outstanding(Mil.): 21.55
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 8.05 19.24
EPS (TTM): -0.85 -- --
ROI: -992.44 14.06 0.44
ROE: -- 17.33 15.61

Earnings vs. Estimates